RLS Global AB logo

RLS - RLS Global AB News Story

SEK4.48 -0.1  -2.2%

Last Trade - 5:00pm

Sector
Healthcare
Size
Micro Cap
Market Cap £25.4m
Enterprise Value £24.8m
Revenue £104k
Position in Universe 1375th / 1872

BRIEF-RLS Global: ChloraSolv Regulatory Approved In Kuwait For Diabetic Foot Ulcers

Mon 31st May, 2021 7:06am
May 31 (Reuters) - RLS Global AB  RLSC.ST :
    * CHLORASOLV IS REGULATORY APPROVED IN KUWAIT FOR DIABETIC
FOOT
ULCERS
    * HAS RECEIVED REGULATORY APPROVAL FOR CHLORASOLV REGARDING
TREATMENT OF DIABETIC FOOT ULCERS IN KUWAIT
    * WITH THIS APPROVAL, RLS HAS ESTABLISHED FIRST MARKET
PRESENCE IN
MIDDLE EAST, WHICH IS AN IMPORTANT REGION FOR RLS
    * PREVALENCE OF DIABETES IN MIDDLE EAST IS VERY HIGH AND IS
EXPECTED TO INCREASE UNTIL 2045 ACCORDING TO INTERNATIONAL
DIABETES FEDERATION*
    * IN KUWAIT, PREVALENCE IN POPULATION IS 12,2 PERCENT
COMPARED TO
4,5 PERCENT IN SWEDEN.

Source text for Eikon:  ID:nWkr4V7dQ7 
Further company coverage:  RLSC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.